Skip to main content
Log in

Orolinguales Angioödem unter systemischer Thrombolyse mit rt-PA

Eine unterschätzte Nebenwirkung

Orolingual angioedema under systemic thrombolysis with rt-PA

An underestimated side effect

  • Originalien
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Das orolinguale Angioödem (OA) ist eine bislang zu wenig beachtete, aber klinisch relevante Nebenwirkung der systemischen Thrombolyse mit dem rekombinanten Gewebeplasminogenaktivator rt-PA bei der akuten zerebralen Ischämie. Sie tritt bei etwa 2% aller Thrombolysepatienten auf, wobei ACE-Hemmer in der Vormedikation das Risiko steigern. Bei meist milder und unilateraler Beteiligung von Lippen und Zunge kann es bei Ausweitung auf den Oropharynx zu potenziell lebensgefährlichen Atemwegsobstruktionen kommen.

Material und Methoden

Die klinischen Daten aller 407 Thrombolysepatienten unserer Klinik im Zeitraum Januar 2006 bis Oktober 2008 wurden einer retrospektiven Analyse auf Symptome eines OA unterzogen.

Ergebnisse

Neun von 407 Patienten (2,2%) wiesen ein OA auf. Die typische klinische Manifestation wird anhand zweier Fallbeispiele aufgeführt und durch einen Überblick der bislang publizierten Fälle vervollständigt.

Schlussfolgerung

Neben einer prophylaktischen Kontrolle der Mundhöhle während und nach Thrombolyse bestehen als Therapieoptionen eine frühzeitige antihistaminerge Therapie sowie ggf. eine Schutzintubation.

Summary

Background

Orolingual angioedema (OA) is an unappreciated complication of acute stroke treatment with recombinant tissue plasminogen activator (rt-PA). It has been described in 2% of patients receiving thrombolysis, and it seems that patients taking angiotensin-converting enzyme inhibitors are especially at risk. Even though the presentation is generally unilateral and limited to lips and tongue, an extension of edema to the oropharynx may lead to life-threatening upper airway obstruction.

Material and methods

In a retrospective analysis of clinical data of 407 patients treated with systemic rt-PA thrombolysis between January 2006 and October 2008 in our department, we describe the occurrence and clinical presentation of OA.

Results

Nine of 407 patients (2.2%) showed clinical signs of OA. Typical presentations of OA are illustrated in case reports describing two of these patients and are completed by an overview of the current literature.

Discussion

Besides prophylactic inspection of the oral cavity during and after thrombolysis, therapeutic options in case of OA include early intravenous antihistaminergic therapy and protective intubation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Agostoni A, Gardinali M, Frangi D et al (1994) Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator Circulation 90:2666–2670

  2. Diserens K, Vuadens P, Michel P et al (2006) Acute autonomic dysfunction contralateral to acute strokes: a prospective study of 100 consecutive cases. Eur J Neurol 13:14–18

    Article  Google Scholar 

  3. Engelter ST, Fluri F, Buitrago-Téllez C et al (2005) Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 252:1167–1170

    Article  PubMed  CAS  Google Scholar 

  4. Hill MD, Lye T, Moss H et al (2003) Hemi-orolingual angioedema and ACE inhibition after alteplase treatement of stroke. J Neurol 60:1525–1527

    CAS  Google Scholar 

  5. Hill MD, Barber PA, Takahashi J et al (2000) Anaphylactoid reactions and angioedema during alteplase treatement of acute ischemic stroke. CMAJ 162:1281–1284

    PubMed  CAS  Google Scholar 

  6. Marder VJ, Brenner B, Totterman S et al (1992) Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. J Lab Clin Med 119:485–495

    PubMed  CAS  Google Scholar 

  7. Massell D, Gill JB, Cairns JA (1991) Anaphylactoid reaction during infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction. Can J Cardiol 7:298–302

    Google Scholar 

  8. Molinaro G, Gervais N, Adam A (2002) Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatement – an in vitro experimental approach. Stroke 33:1712–1716

    Article  PubMed  CAS  Google Scholar 

  9. Pancioli A, Brott T, Donaldson V, Miller R (1997) Asymmetric angioneurotic edema associated with thrombolysis for acute stroke. Ann Emerg Med 30:227–229

    Article  PubMed  CAS  Google Scholar 

  10. Reed BR, Chen AB, Tanswell P et al (1990) Low incidence of antibodies to recombinant human tissue-plasminogen activator in treated patients. Thromb Haemost 64:276–280

    PubMed  CAS  Google Scholar 

  11. Rudolf J, Grond M, Prince WS et al (1999) Evidence of anaphylaxy after alteplase infusion. Stroke 30:1142–1143

    PubMed  CAS  Google Scholar 

Download references

Interessenskonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Ottomeyer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ottomeyer, C., Sick, C., Hennerici, M. et al. Orolinguales Angioödem unter systemischer Thrombolyse mit rt-PA. Nervenarzt 80, 459–463 (2009). https://doi.org/10.1007/s00115-009-2685-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-009-2685-5

Schlüsselwörter

Keywords

Navigation